Sergio Traversa

Chief Executive Officer at Relmada Therapeutics · 7 reported transactions in 1 company · latest trade Sep 10, 2026

Their record

Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.

Typical move +517.2%, S&P 500 +6.4% over the same days.

1 more is too recent to measure.

Sep 10, 2026 · RLMD

$410K

Sep 9, 2026 · RLMD

$418K

Dec 15, 2025 · RLMD

$113.3K

Nov 5, 2025 · RLMD

$599.5K

Aug 28, 2025 · RLMD

$41.4K

Aug 27, 2025 · RLMD

$86.7K

Aug 26, 2025 · RLMD

$49.9K

7 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Executive Officer at Relmada Therapeutics · 7 reported transactions in 1 company · latest trade Sep 10, 2026

Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.

Typical move +517.2%, S&P 500 +6.4% over the same days.

1 more is too recent to measure.